Blue Chip Partners »

Vaneck Vectors Pharmaceutical etf shares owned by Blue Chip Partners

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Blue Chip Partners from 13F filings

Historical chart of Blue Chip Partners investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Blue Chip Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Blue Chip Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $359k 3.5k 103.17
2025-09-30 $450k 5.0k 90.36
2024-12-31 $2.1M 25k 86.28

More positions owned by Blue Chip Partners

Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Microsoft Corporation (MSFT)
Capital Grp Fixed Incm Etf T Municipal Income (CGMU)
Abbvie (ABBV)
Eli Lilly & Co. (LLY)
Select Sector Spdr Tr State Street Ene (XLE)
Amazon (AMZN)
Visa Com Cl A (V)
Kla Corp Com New (KLAC)
TJX Companies (TJX)
Waste Management (WM)

View all positions for Blue Chip Partners

Top funds holding Vaneck Vectors Pharmaceutical etf

Healthcare Of Ontario Pension Plan Trust Fund
Goldman Sachs Group
British Columbia Investment Management Corporation
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Bnp Paribas Arbitrage, Snc
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Adamsbrown Wealth Consultants
Susquehanna International
UBS Group
LPL Financial

View all funds holding Vaneck Vectors Pharmaceutical etf